Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Keltai

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Clinical Hemorheology and Microcirculation|March 1, 1997
The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarctionK Toth, L Bogar, I Juricskay, et al.
Circulation|January 1, 1987
Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusionH Hod, A S Lew, M Keltai, et al.
Journal of the American College of Cardiology|November 15, 1997
Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve ThrombosisM Lengyel, V Fuster, M Keltai, et al.
Circulation|August 30, 2000
Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) RegistryK Malmberg, S Yusuf, H C Gerstein, et al.
Lancet (London, England)|August 26, 1998
Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry InvestigatorsS Yusuf, M Flather, J Pogue, et al.
Diabetes Care|February 13, 2008
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial, G R Dagenais, H C Gerstein, et al.
European Heart Journal|February 10, 2000
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITK M Akkerhuis, J W Deckers, E Boersma, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
American Heart Journal|June 20, 2006
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events, , S Connolly, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Clinical Hemorheology and Microcirculation|March 1, 1997
The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarctionK Toth, L Bogar, I Juricskay, et al.
Circulation|January 1, 1987
Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusionH Hod, A S Lew, M Keltai, et al.
Journal of the American College of Cardiology|November 15, 1997
Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve ThrombosisM Lengyel, V Fuster, M Keltai, et al.
Circulation|August 30, 2000
Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) RegistryK Malmberg, S Yusuf, H C Gerstein, et al.
Lancet (London, England)|August 26, 1998
Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry InvestigatorsS Yusuf, M Flather, J Pogue, et al.
Diabetes Care|February 13, 2008
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial, G R Dagenais, H C Gerstein, et al.
European Heart Journal|February 10, 2000
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITK M Akkerhuis, J W Deckers, E Boersma, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
American Heart Journal|June 20, 2006
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events, , S Connolly, et al.
Pageof 3